Goralatide (TFA)
Goralatide TFA is an inhibitor of cell cycle progression. Goralatide TFA enhances selectivity of hyperthermic purging of human progenitor cells. Goralatide TFA has the potential for the research of leukemia[1].
Product Specifications
CAS Number
[1796568-94-9]
UNSPSC
12352209
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/goralatide-tfa.html
Purity
99.0
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 250 mg/mL (ultrasonic)
Smiles
O=C(O)[C@H]1N(C([C@H](CCCCN)NC([C@H](CC(O)=O)NC([C@H](CO)NC(C)=O)=O)=O)=O)CCC1.OC(C(F)(F)F)=O
Molecular Formula
C22H34F3N5O11
Molecular Weight
601.53
References & Citations
[1]Wierenga PK, et al. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression. Bone Marrow Transplant. 1998;21 (1) :73-78.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
